Dendritic Cell Dynamics in Peripheral and Lymphoid Tissues in SIV Infection
Dendritic Cell Dynamics in Peripheral and Lymphoid Tissues in SIV Infection
批准号:
8044793
负责人:
Simon M Barratt-Boyes
金额:
$49.18万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-04-01 至 2012-03-31
关键词:
AccountingAcquired Immunodeficiency SyndromeAnimalsAntigen-Presenting CellsAntigensAntiviral AgentsApoptosisBindingBiological AssayBloodBlood CirculationBone MarrowCD34 geneCD4 Positive T LymphocytesCell CountCell Cycle KineticsCellsCellular biologyCessation of lifeChronicComplexDataDendritic CellsDendritic cell activationDiseaseEnzyme-Linked Immunosorbent AssayEpidermisFamilyFlow CytometryFrequenciesGenerationsHIV-1HematopoiesisHomeostasisHumanImmune responseImmunityImmunofluorescence ImmunologicIn SituIn VitroIndividualInfectionInflammationInflammatoryInterferon Type IInterferonsLabelLeadLigandsLinkLymphaticLymphoid TissueMacaca mulattaMeasuresMediatingMesenteryModelingMonkeysMucous MembraneMyelogenousPeripheralPlayPopulationProcessProductionRecoveryResearch PersonnelRoleSIVSimian Acquired Immunodeficiency SyndromeSkinSourceSpleenStagingStaining methodStainsSuspension substanceSuspensionsT-LymphocyteTNF-related apoptosis-inducing ligandTNFRSF10A geneTNFRSF10B geneTestingTherapeuticTimeTissuesTumor Necrosis Factor-alphaViremiaVirusVirus Diseasesantiretroviral therapycytokinedensityimmune activationinterleukin-12 subunit p40lymph nodesnonhuman primatenovelpathogenperipheral bloodreceptortraffickingtransmission processtumor necrosis factor receptor 1A
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Dendritic cells (DC) are professional antigen-presenting cells that are critical in the innate and acquired immune response to pathogens. DC exist as two major subsets in humans and nonhuman primates, being classical or myeloid DC (mDC) and plasmacytoid DC (pDC). mDC and pDC are lost from the circulation in human immunodeficiency virus type 1 (HIV)-infected individuals, which is thought to be due to recruitment of circulating cells to lymphoid tissues and is associated with progression to disease. The proposed recruitment of pDC to lymph nodes has been used to explain the increased expression of IFN-a in lymph nodes in HIV- infected individuals, which in turn has been linked to TNF-related apoptosis-inducing ligand (TRAIL)-mediated CD4+ T cell apoptosis. However, the effects of infection on DC subsets in lymphoid tissues remain largely unexplored. Using the rhesus macaque/simian immunodeficiency virus (SIV) model, we have shown that DC numbers are increased in lymph nodes at the peak of viremia, consistent with recruitment through inflammation. However, during simian AIDS, DC are depleted from blood, peripheral and mesenteric lymph nodes and spleen, and are reduced in density in skin. These data suggest a highly dynamic process of DC recruitment to and subsequent loss from lymphoid tissues during SIV infection. Our proposal aims to build on these novel findings, focusing in particular on the mechanism(s) of DC loss. Our preliminary data indicate that lymph node DC in monkeys with AIDS are activated and prone to spontaneous death in culture. We hypothesize that DC loss from lymphoid tissues during pathogenic SIV infection is primarily mediated by factors relating to chronic inflammation and activation. To test this hypothesis we will comprehensively analyze DC subsets in blood and tissues after intravaginal inoculation of rhesus macaques with SIVmac251. We will administer antiretroviral therapy (ART) in a subset of animals, which will aid in dissecting the mechanism of cell loss by reducing immune activation. We will (1) Determine DC kinetics and activation and the relationship to tissue inflammation in SIV infection; (2) Determine the role of direct infection in DC loss in SIV infection; (3) Determine the role of apoptosis in DC loss during SIV infection and (4) Determine the capacity for pDC and mDC to produce IFN-a and Th1-stimulating cytokines during SIV infection. These studies will greatly advance our understanding of complex DC biology in HIV infection.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Host Defense Small Molecule Development for COVID-19 Treatment by Targeting Lysosome
-
批准号:10735492
-
项目类别:
-
资助金额:$76.51万
-
财政年份:2023
-
负责人:Simon M Barratt-Boyes
-
依托单位:
Immunity to Live Mosquito Probing and Flavivirus Infection in Human Skin
-
批准号:9807252
-
项目类别:
-
资助金额:$21.06万
-
财政年份:2019
-
负责人:Simon M Barratt-Boyes
-
依托单位:
Dendritic Cell Dynamics in Peripheral and Lymphoid Tissues in SIV Infection
-
批准号:8473151
-
项目类别:
-
资助金额:$64.02万
-
财政年份:2012
-
负责人:Simon M Barratt-Boyes
-
依托单位:
Dendritic Cell Dynamics in Peripheral and Lymphoid Tissues in SIV Infection
-
批准号:8828540
-
项目类别:
-
资助金额:$68.43万
-
财政年份:2012
-
负责人:Simon M Barratt-Boyes
-
依托单位:
Dendritic Cell Dynamics in Peripheral and Lymphoid Tissues in SIV Infection
-
批准号:8416465
-
项目类别:
-
资助金额:$68.42万
-
财政年份:2012
-
负责人:Simon M Barratt-Boyes
-
依托单位:
Dendritic Cell Dynamics in Peripheral and Lymphoid Tissues in SIV Infection
-
批准号:8648972
-
项目类别:
-
资助金额:$69.33万
-
财政年份:2012
-
负责人:Simon M Barratt-Boyes
-
依托单位:
Dendritic Cell Dynamics in Peripheral and Lymphoid Tissues in SIV Infection
-
批准号:7923493
-
项目类别:
-
资助金额:$16.78万
-
财政年份:2009
-
负责人:Simon M Barratt-Boyes
-
依托单位:
Dendritic Cell Dynamics in Peripheral and Lymphoid Tissues in SIV Infection
-
批准号:7385998
-
项目类别:
-
资助金额:$46.94万
-
财政年份:2007
-
负责人:Simon M Barratt-Boyes
-
依托单位:
Dendritic Cell Dynamics in Peripheral and Lymphoid Tissues in SIV Infection
-
批准号:7782672
-
项目类别:
-
资助金额:$51.41万
-
财政年份:2007
-
负责人:Simon M Barratt-Boyes
-
依托单位:
Dendritic Cell Dynamics in Peripheral and Lymphoid Tissues in SIV Infection
-
批准号:7572945
-
项目类别:
-
资助金额:$49.56万
-
财政年份:2007
-
负责人:Simon M Barratt-Boyes
-
依托单位:
Dendritic Cell Dynamics in Peripheral and Lymphoid Tissues in SIV Infection
-
批准号:7284452
-
项目类别:
-
资助金额:$45.54万
-
财政年份:2007
-
负责人:Simon M Barratt-Boyes
-
依托单位:
Whole Autologous SIV Vaccine Using Dendritic Cells
-
批准号:7039070
-
项目类别:
-
资助金额:$34.98万
-
财政年份:2002
-
负责人:Simon M Barratt-Boyes
-
依托单位:
Whole Autologous SIV Vaccine Using Dendritic Cells
-
批准号:6627837
-
项目类别:
-
资助金额:$35.93万
-
财政年份:2002
-
负责人:Simon M Barratt-Boyes
-
依托单位:
Whole Autologous SIV Vaccine Using Dendritic Cells
-
批准号:6880056
-
项目类别:
-
资助金额:$36.01万
-
财政年份:2002
-
负责人:Simon M Barratt-Boyes
-
依托单位:
Whole Autologous SIV Vaccine Using Dendritic Cells
-
批准号:6496576
-
项目类别:
-
资助金额:$35.97万
-
财政年份:2002
-
负责人:Simon M Barratt-Boyes
-
依托单位:
Whole Autologous SIV Vaccine Using Dendritic Cells
-
批准号:6722846
-
项目类别:
-
资助金额:$36.07万
-
财政年份:2002
-
负责人:Simon M Barratt-Boyes
-
依托单位:
PRIMATE MODEL OF DENDRITIC CELL-BASED IMMUNOTHERAPY
-
批准号:6031023
-
项目类别:
-
资助金额:$9.99万
-
财政年份:1996
-
负责人:Simon M Barratt-Boyes
-
依托单位:
PRIMATE MODEL OF DENDRITIC CELL-BASED IMMUNOTHERAPY
-
批准号:2445912
-
项目类别:
-
资助金额:$5.61万
-
财政年份:1996
-
负责人:Simon M Barratt-Boyes
-
依托单位:
ANIMAL MODEL OF DENDRITIC CELL-BASED IMMUNOTHERAPY
-
批准号:2689583
-
项目类别:
-
资助金额:$0.86万
-
财政年份:1996
-
负责人:Simon M Barratt-Boyes
-
依托单位:
PRIMATE MODEL OF DENDRITIC CELL-BASED IMMUNOTHERAPY
-
批准号:2736186
-
项目类别:
-
资助金额:$8.46万
-
财政年份:1996
-
负责人:Simon M Barratt-Boyes
-
依托单位:
海外基金